Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost et al.|JNCI Journal of the National Cancer Institute|2013Cited by 946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate CancerElena Castro, Rosalind A. Eeles, Chee Goh et al.|Journal of Clinical Oncology|2013Cited by 833
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Nazneen Rahman, Clare Turnbull et al.|Nature Genetics|2011Cited by 545
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerElena Castro, Rosalind A. Eeles, Chee Goh et al.|European Urology|2014Cited by 374
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutationsTimothy R. Rebbeck, Carole Brewer, Tara M. Friebel et al.|Human Mutation|2018Cited by 319